latest news releases from the newsroom
Chelsea Therapeutics Reports Findings From Open-Label Titration Phase of Pivotal Phase III Trials
CHARLOTTE, N.C., Feb. 17, 2009 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) announced that the Company has completed a second analysis of data from the open-label titration portion of its Phase III Study 302 which demonstrated patients treated with Droxidopa, a synthetic precursor to norepinephrine, showed a similarly robust reduction in the severity of symptoms associated with neurogenic orthostatic hypotension (NOH) and a improvement standing systolic blood pressure as reported in November 2008.
Highway Holdings Limited
Highway Holdings Reports Fiscal 2009 Third Quarter Results
HONG KONG, Feb. 17, 2009 (GLOBE NEWSWIRE) -- Highway Holdings Limited (Nasdaq:HIHO) today reported results for its third fiscal quarter ended December 31, 2008, representing a return to profitability on a year-over-year basis, a strong balance sheet and continued improvements to operating efficiencies.
Mercer International Inc.
Mercer International Inc. Announces Completion of Contribution Agreement With the Government of Canada
NEW YORK, Feb. 17, 2009 (GLOBE NEWSWIRE) -- Mercer International Inc. (Nasdaq:MERC) (TSX:MRI.U) today announced that its Celgar mill has signed a contribution agreement ("Contribution Agreement") with the Canadian federal government pursuant to Canada's ecoEnergy for Renewable Power Program. The program was established to increase Canada's supply of clean electricity from renewable sources, such as biomass, by providing funding for renewable energy projects such as the Celgar mill's new green energy project (the "Celgar Energy Project").
Power Medical Interventions, Inc.
Power Medical Interventions, Inc. Receives FDA 510(k) Marketing Clearance for i60RL Intelligent Surgical Instruments(tm)
LANGHORNE, Pa., Feb. 17, 2009 (GLOBE NEWSWIRE) -- Power Medical Interventions(r), Inc. (Nasdaq:PMII), a leader in developing and commercializing Intelligent Surgical Instruments(tm), announced today that the U.S. Food and Drug Administration has cleared its 510(k) application for marketing its patented i60RL Intelligent Surgical Instrument. The i60RL Intelligent Surgical Instrument is the world's first reverse pivot linear cutter, designed to improve medical outcomes by providing surgeons with greater access to important anatomical sites that are currently difficult to reach. The i60RL will be available for applications throughout the digestive tract. The Company intends to launch the product in April 2009.
Mondo Super X Performance Track At Bates College Provides Competitive Edge for School's Athletes
LEWISTON, Maine, Feb. 17, 2009 (GLOBE NEWSWIRE) -- The Mondo Super X Performance track recently installed in the Merrill Indoor Gymnasium and Field House at Bates College does more than provide the school with a top-notch indoor facility. In conjunction with the Mondo outdoor track that was installed in 2001, it secures Bates' position as one of the pre-eminent collegiate track venues in New England.